United States · Funded startup
5 rounds we have observed, with the 10 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$94Mraised across 5 rounds since 2006, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding recordSEC filing: $8.1M sold, first sale Dec 2010
Reported by endocyte.comSEC filing: $8.1M sold, first sale Dec 2010
Sanderling Ventures
Blue Chip Venture Company
Triathlon Medical Venture PartnersReported by onbiovc.comSEC filing: $27M sold, first sale Aug 2009
Sanderling VenturesBlue Chip Venture CompanyTriathlon Medical Venture Partners
CID CapitalFrom a historical funding record
Sanderling VenturesBlue Chip Venture CompanyTriathlon Medical Venture PartnersFrom a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Sanderling VenturesBlue Chip Venture CompanyTriathlon Medical Venture PartnersAmerican Bailey Ventures
SVB Capital
MidCap FinancialCID CapitalTwilight Venture PartnersCID Equity PartnersMissing a round, or an investor who was in one? Tell us.
Endocyte's investors include Burrill & Company, Sanderling Ventures, Blue Chip Venture Company, Triathlon Medical Venture Partners and American Bailey Ventures, and 5 more on record.
Endocyte has raised $94M across 5 rounds since 2006.
Endocyte's most recent round was a Debt of $8.1M in Dec 2010.
Endocyte's largest round on record is $30M (Series D), in Nov 2006.
Endocyte's first round on record, in Nov 2006, was backed by Burrill & Company, Sanderling Ventures and Blue Chip Venture Company and 3 others.
Endocyte's latest named round is a Debt, in Dec 2010.
Endocyte is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·